Back

The PARTHENOPE Trial: Personalized vs Standard DAPT after PCI

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Clinical Trials: antithrombotic strategies and PCI advances Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Associate Professor Raffaele Piccolo

University of Naples Federico II, Naples (Italy)

3 More presentations in this session

Presentation thumbnail
TADCLOT- Twice A Day CLOpidogrel vs. Ticagrelor post STEMI
Professor A. Hakeem (Karachi, PK)
Slides Video
Presentation thumbnail
Device success in the Multivessel TALENT trial
Professor P. Serruys (Galway, IE)
Slides Video
Presentation thumbnail
APERITIF trial
Professor E. Puymirat (Paris, FR)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Clinical Trials: antithrombotic strategies and PCI advances
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
A shorter duration of dual-antiplatelet therapy following percutaneous coronary intervention: a meta-analysis of randomized clinical trials
thumbnail
Congress Session
Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more
thumbnail
Congress Presentation
Following an acute coronary syndrome, the default duration of dual antiplatelet therapy should be 12 months: pro

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources